Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 Knowledge of community pharmacists on NSAIDs associated renal and GIT adverse effects (n = 751)

From: Evaluation of the knowledge, practices, and attitudes of community pharmacists towards adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs): a cross-sectional study

Knowledge item

Frequency (%)

NSAIDs are indicated in all of the following conditions except

Pain

18 (2.4%)

Acute gout

131 (17.4%)

Chronic gout

578 (76.8%)

Headache

24 (3.2%)

NSAIDs interact with all of the following drugs except

Diuretics

184 (24.4%)

Clopidogrel

121 (16.1%)

Warfarin

89 (11.8%)

Albuterol

357 (47.4%)

NSAIDs are contraindicated in all of the following conditions except

History of GIT bleeding

63 (8.4%)

Asthma

90 (12.0%)

Hypersensitivity to Ibuprofen

106 (14.1%)

Osteoporosis

492 (65.3%)

Which of the following is a gastrointestinal side effect of NSAIDs

Upper gastrointestinal bleeding

492 (65.3%)

Inflammatory bowel disease

59 (7.8%)

Irritable bowel syndrome

56 (7.4%)

Crohn’s disease

144 (19.1%)

Unlike systemic NSAIDs, topical NSAIDs have lower risk of causing epithelial injury in the gastrointestinal tract

True

633 (84.1%)

False

54 (7.2%)

I do not know

64 (8.5%)

Inhibition of prostaglandin synthesis causes

Decreased gastric acid secretion, increased bicarbonate secretion and increased mucus secretion

133 (17.7%)

Increased gastric acid secretion, decreased bicarbonate secretion and decreased mucus secretion

474 (62.9%)

None of the above

144 (19.1%)

Risk factors for developing gastric injury include all of the following except

High dose of NSAID

67 (8.9%)

Previous medical history of gastrointestinal disease (e.g. ulcers)

37 (4.9%)

Age less than 65 years

544 (72.2%)

Concomitant steroid therapy of 10 mg/day or greater

103 (13.7%)

The risk of NSAID-induced kidney injury increases with

Lower NSAID doses

40 (5.3%)

Concomitant use of ACE inhibitors

565 (75.0%)

Shorter duration of NSAID therapy

76 (10.1%)

Concomitant use of topical capsaicin

70 (9.3%)

All the following patients should avoid NSAIDs except

Patients having a higher risk of stomach bleeding

27 (3.6%)

Patients having stomach problems, including heartburn

53 (7.0%)

Patients having high blood pressure, heart disease, liver cirrhosis, or kidney disease

67 (8.9%)

Patients with only hypothyroidism, for which they take levothyroxine orally

550 (73.0%)

Patients taking a diuretic for high blood pressure or heart failure

54 (7.2%)

Which of the following is the most appropriate alternative for a patient at high risk for NSAID induced acute kidney injury after an acute musculoskeletal injury?

Naproxen

88 (11.7%)

Capsaicin cream

134 (17.8%)

Acetaminophen/paracetamol

461 (61.2%)

Colchicine

68 (9.0%)

  1. NSAIDs nonsteroidal anti-inflammatory drugs